Nature

Haematological diseases articles from across Nature Portfolio

Haematological diseases are pathological conditions primarily affecting the blood or blood-producing organs. This group of disorders includes, but is not limited to, various types of anaemia, blood cancers and haemorrhagic conditions.

Related Subjects

Latest Research and Reviews

Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk
- Natalie S. Callander
- Rebecca Silbermann
- Peter M. Voorhees
ResearchOpen Access22 Apr 2024 Blood Cancer Journal
Volume: 14, P: 69
Investigation of the effectiveness of a classification method based on improved DAE feature extraction for hepatitis C prediction
- Lin Zhang
- Jixin Wang
- Weigang Wang
ResearchOpen Access21 Apr 2024 Scientific Reports
Volume: 14, P: 9143
Bispecific CAR T cell therapy targeting BCMA and CD19 in relapsed/refractory multiple myeloma: a phase I/II trial

CAR-T cell therapies targeting BCMA have shown promising responses in patients with multiple myeloma (MM), however primary resistance and relapse are frequently observed. Here the authors report the results of a phase I//II study of bispecific CAR T-cells targeting BCMA and CD19 in relapsed/refractory MM.
- Ming Shi
- Jiaojiao Wang
- Jiang Cao
ResearchOpen Access20 Apr 2024 Nature Communications
Volume: 15, P: 3371
Identification of metabolism-related key genes as potential biomarkers for pathogenesis of immune thrombocytopenia
- Xiangmei Xu
- Jiamin Zhang
- Lin Liu
ResearchOpen Access19 Apr 2024 Scientific Reports
Volume: 14, P: 9040
Caspase 8 deletion causes infection/inflammation-induced bone marrow failure and MDS-like disease in mice
- Shanhui Liu
- Kanak Joshi
- Jiwang Zhang
ResearchOpen Access18 Apr 2024 Cell Death & Disease
Volume: 15, P: 278
Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibody
- Sylwia A. Stefańczyk
- Ilona Hagelstein
- Melanie Märklin
ResearchOpen Access18 Apr 2024 Blood Cancer Journal
Volume: 14, P: 67

All Research & Reviews

News and Comment

Age-stratified analysis reveals arterial thrombosis as a predictor for gender-related second cancers in myeloproliferative neoplasms: a case-control study
- Arianna Ghirardi
- Alessandra Carobbio
- Tiziano Barbui
CorrespondenceOpen Access22 Apr 2024 Blood Cancer Journal
Volume: 14, P: 68
In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease
- Thomas Lund
- Michael Tveden Gundesen
- Fredrik Schjesvold
CorrespondenceOpen Access15 Apr 2024 Blood Cancer Journal
Volume: 14, P: 65
Busulfan plus cyclophosphamide vs. total body irradiation plus cyclophosphamide for allogeneic hematopoietic stem cell transplantation in patients with acute T lymphoblastic leukemia: a large-scale propensity score matching-based study
- Yifan Shen
- Minyuan Liu
- Yang Xu
Correspondence13 Apr 2024 Bone Marrow Transplantation
P: 1-3
Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium
- Aimaz Afrough
- Hamza Hashmi
- Yi Lin
CorrespondenceOpen Access12 Apr 2024 Blood Cancer Journal
Volume: 14, P: 63
Pacing of clonal expansion is dictated by its underlying mutation
- Andrea Tavosanis
Research Highlights10 Apr 2024 Nature Cardiovascular Research
Volume: 3, P: 404
CEBPA bZIP in-frame mutations in acute myeloid leukemia: prognostic and therapeutic implications
- Fenghong Zhang
- Zhen Shen
- Suning Chen
CorrespondenceOpen Access09 Apr 2024 Blood Cancer Journal
Volume: 14, P: 59

All News & Comment

Search

Advanced search

Quick links